These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 10516884
1. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease. Künig G, Pogarell O, Möller JC, Delf M, Oertel WH. Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884 [Abstract] [Full Text] [Related]
2. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG. Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211 [Abstract] [Full Text] [Related]
3. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial. Möller JC, Oertel WH, Köster J, Pezzoli G, Provinciali L. Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540 [Abstract] [Full Text] [Related]
4. Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor. Navan P, Findley LJ, Jeffs JA, Pearce RK, Bain PG. Mov Disord; 2003 Nov; 18(11):1324-31. PubMed ID: 14639675 [Abstract] [Full Text] [Related]
5. The use of pramipexole, a novel dopamine (DA) agonist, in advanced Parkinson's disease. Molho ES, Factor SA, Weiner WJ, Sanchez-Ramos JR, Singer C, Shulman L, Brown D, Sheldon C. J Neural Transm Suppl; 1995 Nov; 45():225-30. PubMed ID: 8748629 [Abstract] [Full Text] [Related]
6. Pramipexole in the treatment of Parkinson's disease: new developments. Möller JC, Oertel WH. Expert Rev Neurother; 2005 Sep; 5(5):581-6. PubMed ID: 16162081 [Abstract] [Full Text] [Related]
7. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease. Linazasoro G, Spanish Dopamine Agonists Study Group. J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015 [Abstract] [Full Text] [Related]
9. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D. Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823 [Abstract] [Full Text] [Related]
20. Pramipexole. A review of its use in the management of early and advanced Parkinson's disease. Dooley M, Markham A. Drugs Aging; 1998 Jun; 12(6):495-514. PubMed ID: 9638397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]